XML 30 R32.htm IDEA: XBRL DOCUMENT

Segment Data - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Mar. 31, 2014 Segment
Segment Reporting [Abstract]
Number of principal business segments	3
Correction of misallocation of costs, description	Segment Operating Income for the Medical and Biosciences segments for the six months ended March 31, 2014 reflect a correction of a $6 million misallocation of costs between the segments for the three months ended December 31, 2013 which was identified subsequent to the issuance of the Company’s condensed consolidated financial statements for the first quarter of fiscal year 2014. This misallocation, which had no impact on the Company’s consolidated results of operations, financial position, or cash flows, resulted in an understatement of the Medical segment’s selling and administrative expense with an offsetting overstatement of the Biosciences segment’s selling and administrative expense.
Correction of misallocation of costs	$ 6

Disclosure made in interim financial reports about error corrections and adjustments related to prior interim periods of the current fiscal year, which includes: (a) the effect on income from continuing operations, net income, and related per share amounts for each prior interim period of the current fiscal year, and (b) income from continuing operations, net income, and related per share amounts for each restated prior interim period. Disclosure also includes the effect of the adjustment on the balance of retained earnings (or other applicable equity accounts) for any period presented.

+ References+ Details